BamSEC and AlphaSense Join Forces
Learn More

aTyr Pharma Inc. – Material Contracts

NASDAQ: ATYR    
Share price (11/17/26): $4.99    
Market cap (11/17/26): $12.7 million

Material Contracts Filter

EX-10.6
from 10-Q 9 pages Consulting Agreement
12/34/56
EX-10.5
from 10-Q 10 pages September 30, 2026 Nancy E. Denyes via Email Re: Separation Agreement Dear Nancy: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That aTyr Pharma, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1
12/34/56
EX-10.4
from 10-Q 8 pages Consulting Agreement
12/34/56
EX-10.3
from 10-Q 10 pages September 30, 2026 Jill M. Broadfoot Re: Separation Agreement Dear Jill: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That aTyr Pharma, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1
12/34/56
EX-10.2
from 10-Q 5 pages August 7, 2026 Mr. Brandon Yaras, Cpa [***] [***] Re: Amended and Restated Offer of Employment
12/34/56
EX-10.1
from 10-Q 14 pages aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan
12/34/56
EX-10.2
from 10-Q 24 pages aTyr Pharma, Inc. 2022 Inducement Plan Adopted by the Compensation Committee: March 21, 2022 Amended by the Compensation Committee: March 21, 2025
12/34/56
EX-10.1
from 8-K 13 pages aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan
12/34/56
EX-10.1
from 8-K 13 pages Atyr Pharma, Inc. 2015 Stock Option and Incentive Plan
12/34/56
EX-10.1
from 10-Q 6 pages First Amendment to Lease Between San Diego Creekside, LLC and Atyr Pharma, Inc
12/34/56
EX-10.19
from 10-K 3 pages Atyr Pharma, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 14 pages Atyr Pharma, Inc. 2015 Stock Option and Incentive Plan
12/34/56
EX-10.1
from 8-K 94 pages Lease Creekside Labs San Diego Creekside, LLC, a Delaware Limited Liability Company, as Landlord, and Atyr Pharma, Inc., a Delaware Corporation, as Tenant
12/34/56
EX-10.4
from 10-Q 12 pages Atyr Pharma, Inc. Stock Option Grant Notice
12/34/56
EX-10.3
from 10-Q 23 pages Atyr Pharma, Inc. 2022 Inducement Plan Adopted by the Compensation Committee: March 21, 2022
12/34/56
EX-10.2
from 8-K 5 pages Atyr Pharma, Inc. 2015 Employee Stock Purchase Plan
12/34/56
EX-10.1
from 8-K 13 pages Atyr Pharma, Inc. 2015 Stock Option and Incentive Plan
12/34/56
EX-10.20
from 10-K 23 pages Atyr Pharma, Inc. Common Stock ($0.001 Par Value Per Share) Capital on Demand™ Sales Agreement
12/34/56
EX-10.1
from 8-K 13 pages Atyr Pharma, Inc. 2015 Stock Option and Incentive Plan
12/34/56
EX-10.19
from 10-K ~1 page First Amendment to Employment Agreement
12/34/56